Amberstone Biosciences (Series A)
Funding Details
Awarder
Inbox
Date Award
January 3, 2022
Vertical
Biotherapeutics
Funding Amount
$12,000,000
Company Info
Founding Year
2018
Founders
George Wu
Market
Solid tumor cancers and other diseases
Location
Laguna Hills, California, USA
Coinvestors
ChangRong Capital, Co-win Ventures, Lifespan Investments, Sinovation Ventures, Viva BioInnovator
Company Description

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.